Product Information
VALACYCLOVIR HCL 500 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.2289 per EA under NDC 62135061330. Its NADAC has been published 130 times since Apr 10, 2024.
FDA first approved this application on Mar 18, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Chartwell RX LLCNDC
62135061330
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VALACYCLOVIR HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209553FDA Approved
3/18/2020
TE Code
AB
On Market Since
10/1/2018
Pharmacological Classes
Price Statistics
The NADAC for VALACYCLOVIR HCL 500 MG TABLET has been published 130 times since Apr 10, 2024, and over the history we have for it it has declined 18.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2289 per EA |
|---|---|
| All-time high | $0.2812 (Apr 10, 2024) |
| All-time low | $0.2043 (Nov 20, 2024) |
| 52-week high | $0.2349 |
| 52-week low | $0.2228 |
| Median price | $0.2349 |
| Average price | $0.2412 |
| Largest weekly change | -22.3% (Nov 20, 2024) |
| Weeks tracked | 130 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Valacyclovir market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VALACYCLOVIR HCL 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VALACYCLOVIR HCL 500 MG TABLET, manufactured by Chartwell RX LLC, is $0.2289 per EA (NDC 62135061330), effective Sep 30, 2026.
How has the price of VALACYCLOVIR HCL 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for VALACYCLOVIR HCL 500 MG TABLET has declined 18.6%. It has been tracked across 130 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for VALACYCLOVIR HCL 500 MG TABLET?
Since Apr 10, 2024, the NADAC for VALACYCLOVIR HCL 500 MG TABLET has ranged from a low of $0.2043 (Nov 20, 2024) to a high of $0.2812 (Apr 10, 2024), with a median of $0.2349 per EA.
Are there cheaper alternatives to VALACYCLOVIR HCL 500 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VALACYCLOVIR HCL 500 MG TABLET, is $0.2240 per EA — about 2% below VALACYCLOVIR HCL 500 MG TABLET.
Who manufactures VALACYCLOVIR HCL 500 MG TABLET?
VALACYCLOVIR HCL 500 MG TABLET (NDC 62135061330) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.